A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People With Hairy Cell Leukemia (HCL)
for Hairy Cell Leukemia
Drug: Rituximab
Sites in Harrison, Uniondale +8 more locations
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All·Age: 18+
Code: NCT06561360·Phase 2·Recruiting·Listed Aug 2024